Circulating microparticle tissue factor activity Is increased in patients with cirrhosis

Authors

  • Pierre-Emmanuel Rautou M.D., Ph.D,

    1. Department of Medicine, Division of Hematology and Oncology, McAllister Heart Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC
    2. Service d'Hépatologie, Hôpital Beaujon, Clichy, France
    Search for more papers by this author
  • Anne-Clémence Vion,

    1. INSERM U970, Paris Cardiovascular Research Center–PARCC, Université Paris Descartes, Paris, France
    Search for more papers by this author
  • James P. Luyendyk Ph.D,

    1. Department of Pathobiology and Diagnostic Investigation, Michigan State University, East Lansing, MI
    Search for more papers by this author
  • Nigel Mackman Ph.D

    1. Department of Medicine, Division of Hematology and Oncology, McAllister Heart Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC
    Search for more papers by this author

  • Potential conflict of interest: Nothing to report.

  • P.-E.R. was supported by the Philippe Foundation and by an American Heart Association Mid-Atlantic postdoctoral fellowship (12POST11970008). This work was supported by the Société Nationale Française de Gastroentérologie (bourse Robert Tournut), the Association Française pour l'Étude du Foie, and the National Institutes of Health (grant no. ES017537 [to J.L.] and grant no. HL095096 to [N.M.]).

No abstract is available for this article.

Ancillary